Back to Search
ALAN BARNETT, PH.D.
PH.D.
Clinical Psychologist
NPI: 1598944456Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
6196(NY)
Research & Publications (20)
Introduction: focusing on the psychoanalyst's intentions in theory of technique.
PMID 18999946·Psychoanal Rev·2008
8-other
Discussion: what is the theoretical yield in studying the psychoanalyst's intentions?
PMID 18999954·Psychoanal Rev·2008
8-other
Translating science into clinical practice: focus on vildagliptin in combination with metformin.
PMID 19385980·Diabetes Obes Metab·2009
6-review
UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).
PMID 19267255·Eur Arch Psychiatry Clin Neurosci·2009
4-observational
New treatments in type 2 diabetes: a focus on the incretin-based therapies.
PMID 18771570·Clin Endocrinol (Oxf)·2009
6-review
Redefining the role of thiazolidinediones in the management of type 2 diabetes.
PMID 19436665·Vasc Health Risk Manag·2009
6-review
The future of inhaled insulin and incretinmimetics in the management of diabetes.
PMID 18684423·Prim Care Diabetes·2008
6-review
Analytic steady-state space use patterns and rapid computations in mechanistic home range analysis.
PMID 18064464·J Math Biol·2008
7-preclinical
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).
PMID 18494813·Diabetes Obes Metab·2008
4-observational
The importance of treating cardiometabolic risk factors in patients with type 2 diabetes.
PMID 18398806·Diab Vasc Dis Res·2008
6-review
Insulin for type 2 diabetes: choosing a second-line insulin regimen.
PMID 19143853·Int J Clin Pract·2008
8-other
A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies.
PMID 17559747·Curr Med Res Opin·2007
6-review
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
PMID 18158075·Clin Ther·2007
4-observational
Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
PMID 17877648·Int J Clin Pract·2007
4-observational
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
PMID 17656425·J Psychopharmacol·2007
6-review
Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.
PMID 17593273·Int J Clin Pract Suppl·2007
6-review
Inhaled human insulin (Exubera): clinical profile and patient considerations.
PMID 17583178·Vasc Health Risk Manag·2007
6-review
Insulin glargine in the treatment of type 1 and type 2 diabetes.
PMID 17319470·Vasc Health Risk Manag·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 120 E 81ST ST, 1C
NEW YORK, NY 10028 - Phone
- (212) 861-4741
Quick Facts
- NPI
- 1598944456
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile